Pharmaceuticals Pricing Board (HILA), Finnish Medicines Agency (Fimea), Council for Choices in Health Care in Finland (COHERE Finland), Finnish Coordinating Center for Health Technology Assessment (FinCCHTA) and Social Insurance Institution of Finland (KELA) organize a hearing on methods used for Health Technology Assessment (HTA) on Tuesday April 16th 2024. In the event, the developers are given an opportunity to present their methods potentially used in the upcoming reimbursement submissions or appraisals to Finnish authorities involved in HTA. The methods to be presented include, but are not limited to:
- Indirect treatment comparisons
- Real world evidence on effectiveness and costs of concurrent treatments or consequences of adapting a new treatment alternative
- Measuring health-related quality of life
- Extrapolation of clinical trials
- Methods and software for cost-effectiveness modeling
The first hearing on HTA methods took place on Friday December 9th 2022. Summaries of the presentations are available on HILA website at: https://www.hila.fi/en/hearing-for-hta-method-developers-december-9th-2022/
The hearing is not meant for discussing or giving advice on preparing reimbursement applications or appraisals. The participants may use simulated data, or alternatively when using actual data make sure acquire necessary permits. Discussion will be academic and any feedback that the authorities may provide on the strength and weaknesses of the model are their personal opinions, which may not be cited later when the method is applied in the actual HTA process.
Parties such as pharmaceutical companies, consultancies or universities interested in the hearing are encouraged to register by email to kalle.aaltonen@gov.fi by March 1st 2024. A short summary of the topic as well as the presenters’ names and affiliation. In addition, the presenter candidates should disclose whether they arrive to Helsinki or Kuopio, or if they give the presentation via Teams. The parties chosen to present will be announced by May 15th 2024.
The hearing takes place on Tuesday April 16th 2024 starting at 9.00 am. Each presentation lasts 90 minutes including the discussion. A total of three presentations have been scheduled. Should there be more registrations than the number of presentations available, the ones with highest relevance and urgency to Finnish HTA system will be selected. Furthermore, repetition to the presentations included in the previous event will be attempted to be avoided. The presenters electing to give a face-to-face presentation, are instructed to arrive at the premises of either Hila (Etelä-Esplanadi 4, 00130 Helsinki) or Fimea Hallituskatu 12-14, 70100 Kuopio) at the scheduled time.